Mimi I Hu Selected Research

pralsetinib

1/2022	RET kinase inhibitors for RET-altered thyroid cancers.
1/2021	Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study.
10/2020	Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies.
1/2018	Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mimi I Hu Research Topics

Disease

21	Neoplasms (Cancer) 01/2022 - 06/2009
11	medullary Thyroid cancer 10/2021 - 01/2011
8	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2011
4	Hypercalcemia (Milk Alkali Syndrome) 01/2018 - 09/2013
3	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2015
3	Bone Resorption 09/2014 - 12/2007
2	Hypothyroidism 01/2021 - 10/2018
2	Disease Progression 01/2021 - 02/2011
2	Melanoma (Melanoma, Malignant) 01/2019 - 01/2016
2	Primary Hyperparathyroidism 10/2018 - 12/2016
2	Papillary Thyroid Cancer 01/2018 - 01/2015
2	Breast Neoplasms (Breast Cancer) 08/2013 - 12/2007
2	Hypocalcemia 04/2012 - 03/2011
1	Femoral Fractures (Femoral Fracture) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Fever (Fevers) 01/2022
1	Hypophysitis 01/2021
1	Headache (Headaches) 01/2021
1	Fatigue 01/2021
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2020
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 08/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Thyroiditis 10/2018
1	Thyrotoxicosis 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Hyperplasia 12/2016
1	Spontaneous Fractures (Pathological Fracture) 12/2016
1	Pheochromocytoma 12/2016
1	Diarrhea 10/2015
1	Carcinogenesis 01/2014
1	Acromegaly 08/2013
1	Hypesthesia (Numbness) 04/2012
1	Cushing Syndrome 10/2011
1	Hypoparathyroidism 03/2011
1	Thyroid Nodule (Nodule, Thyroid) 02/2011
1	Lymphadenopathy 02/2011
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 02/2011
1	Osteomalacia 06/2010
1	Necrosis 06/2010
1	Vitamin D Deficiency 06/2009

Drug/Important Bio-Agent (IBA)

5	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2011
4	pralsetinibIBA 01/2022 - 01/2018
4	vandetanib (ZD6474)IBA 01/2021 - 01/2011
4	CalciumIBA 10/2015 - 03/2011
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 01/2014
3	selpercatinibIBA 01/2022 - 10/2020
3	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2018
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2017 - 02/2011
3	Diphosphonates (Bisphosphonates)IBA 01/2015 - 09/2013
3	Denosumab FDA Link 01/2015 - 09/2013
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2021
2	cabozantinibIBA 01/2021 - 10/2020
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 10/2011
2	VemurafenibIBA 01/2019 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 12/2016
2	Vitamin D FDA LinkGeneric 01/2016 - 03/2011
2	Pharmaceutical PreparationsIBA 12/2014 - 01/2011
2	Sorafenib (BAY 43-9006)FDA Link 06/2014 - 05/2014
2	Parathyroid Hormone (Parathormone)IBA 04/2012 - 03/2011
2	GlucocorticoidsIBA 06/2010 - 06/2009
2	Estrogens (Estrogen)FDA Link 06/2009 - 12/2007
1	ElectrolytesIBA 01/2022
1	AntigensIBA 10/2021
1	lenvatinibIBA 10/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	CreatinineIBA 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2018
1	IpilimumabIBA 10/2018
1	NivolumabIBA 10/2018
1	Parathyroid Hormone-Related ProteinIBA 01/2018
1	CytokinesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	25-hydroxyvitamin DIBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	AntidiarrhealsIBA 10/2015
1	Calcium AluminosilicateIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 10/2015
1	ClayIBA 10/2015
1	Thyroglobulin FDA Link 01/2015
1	Octreotide (Sandostatin)FDA LinkGeneric 08/2013
1	Phenylalanine (L-Phenylalanine)FDA Link 02/2011
1	Alanine (L-Alanine)FDA Link 02/2011
1	Methionine (L-Methionine)FDA Link 02/2011
1	Codon (Codons)IBA 02/2011
1	Threonine (L-Threonine)FDA Link 02/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2009
1	Vitamin A (Retinol)FDA LinkGeneric 06/2009

Therapy/Procedure

15	Therapeutics 01/2022 - 06/2009
3	Thyroidectomy 12/2016 - 03/2011
2	Radiotherapy 12/2016 - 06/2009
2	Drug Therapy (Chemotherapy) 06/2010 - 06/2009
1	Time-to-Treatment 10/2020
1	Airway Management 01/2020
1	Parathyroidectomy 10/2018
1	Neck Dissection (Radical Neck Dissection) 01/2018
1	Aftercare (After-Treatment) 03/2011